Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.

Item

http://www.wikidata.org/entity/Q51047922

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.

@en

Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.

@nl

type

Item

label

Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.

@en

Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.

@nl

prefLabel

Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.

@en

Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.

@nl

P1476

Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease

@en

P2093

A Ripoli

http://www.w3.org/2001/XMLSchema#string

G Linsalata

http://www.w3.org/2001/XMLSchema#string

S Mazzucchi

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.

Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia.

Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.

Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats

The serotonergic system in Parkinson's disease.

The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

Levodopa-dyskinesia incidence by age of Parkinson's disease onset.

P304

191-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12314

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25274076

http://www.w3.org/2001/XMLSchema#string

P921

dyskinesia